awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33423016-F83EC05D-A64A-47A0-9D27-A4E8E3F25479
Q33423016-F83EC05D-A64A-47A0-9D27-A4E8E3F25479
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423016-F83EC05D-A64A-47A0-9D27-A4E8E3F25479
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
P2860
Q33423016-F83EC05D-A64A-47A0-9D27-A4E8E3F25479
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423016-F83EC05D-A64A-47A0-9D27-A4E8E3F25479
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a41ada146670d401c042601d332eda125f9603ba
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).